Denali Ventures logo

Denali Ventures

Asia, Tel Aviv, Israel, Herzliya

Description

Denali Ventures, an investment firm, finances companies with methods for controlling significant disease entities and medical conditions.

Investor Profile

Denali Ventures has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (33%)
  • Series D (33%)
  • Series E (33%)

Country Focus

  • Israel (67%)
  • United States (33%)

Industry Focus

  • Biotechnology
  • Ad Targeting
  • Analytics
  • Artificial Intelligence (Ai)
  • Big Data
  • Coupons
  • E-commerce
  • Real Time
  • Software
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Denali Ventures frequently co-invest with?

Gemini Israel Ventures
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 1
CS
Asia, Isabela, Philippines, Australia
Co-Investments: 1
Denali Venture Partners
North America, California, United States, Mountain View
Co-Investments: 1
Morgan Stanley Venture Partners
North America, New York, United States, New York
Co-Investments: 1
Clal Biotechnology Industries
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 2
Wells Fargo Asset Management
North America, California, United States, San Francisco
Co-Investments: 1
Care Capital
North America, New Jersey, United States, Princeton
Co-Investments: 1
Quintiles
North America, North Carolina, United States, Durham
Co-Investments: 1
Cowen Group
North America, New York, United States, New York
Co-Investments: 1
CI
North America, California, United States, Menlo Park
Co-Investments: 1

Which angels does Denali Ventures often collaborate with?

Derek Adelman
North America, California, United States, Atherton
Shared Deals: 1
SY
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Denali Ventures?

Fanplayr

Menlo Park, California, United States

Global leader in online behavioral personalization, artificial intelligence and user privacy

Ad TargetingAnalyticsArtificial Intelligence (AI)Big DataCouponsE-CommerceReal TimeSoftware
Series AMay 20, 2016
Amount Raised: $6,000,000
Gamida Cell

Jerusalem, Yerushalayim, Israel

Gamida Cell is a biopharmaceutical company developing advanced cell therapies for patients with blood cancers and hematologic diseases.

BiotechnologyHealth CareLife ScienceMedical DeviceTherapeutics
Series EMay 15, 2012
Amount Raised: $10,000,000
D Pharm LTD.

Rehovot, HaMerkaz, Israel

D-Pharm is a drug-development company.

BiopharmaBiotechnologyPharmaceutical
Series DOct 16, 2001
Amount Raised: $30,000,000